Cardiology Research Dubrava: Single Centre, Prospective Registry
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 3,000
- 试验地点
- 1
- 主要终点
- freedom from atrial arrhythmias
研究概览
简要总结
Cardiology Research Dubrava registry is a prospective, single centre registry including patients with acute coronary syndrome with and without ST segment elevation, patients with heart failure who were prescribed with SGLT-2 inhibitors, patients implanted with TAVI, patients with venous thromboembolism, patients with pulmonary embolism who underwent thromboaspiration procedure, patients implanted with ICD, CRT and conduction system pacing devices, as well as patients with atrial fibrillation who underwent pulmonary vein isolation and are prescribed with long-term anticoagulation therapy.
详细描述
Cardiology Research Dubrava registry is a prospective, single centre registry including patients with acute coronary syndrome with and without ST segment elevation, patients with heart failure who were prescribed with SGLT-2 inhibitors, patients implanted with TAVI, patients with venous thromboembolism, patients with pulmonary embolism who underwent thromboaspiration procedure, patients implanted with ICD, CRT and conduction system pacing devices, as well as patients with atrial fibrillation who underwent pulmonary vein isolation and are prescribed with long-term anticoagulation therapy.
In this long-term follow-up registry we plan to collect data on clinical status, standard laboratory results including lipidogram values, NTproBNP values after specific interventions (in.ex. TAVI implantation, SGLT2inh prescripition), bleeding complications, and every major cardiovascular event, including cardiovascular death and all cause death.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients implanted with CIED, or with VTE, or with ACS or with TAVI -
排除标准
- •non compliance, not undergoing follow-up at this center
结局指标
主要结局
freedom from atrial arrhythmias
时间窗: 10 years
Freedom from atrial arrhythmias after PVI during mid-term folow-up (1 year) and long-term follow-up
Laboratory levels of NTproBNP
时间窗: 10 years
Laboratory levels of NTproBNP in patients with AFib after PVI, in patients with HF prescribed with SGLT2 inhibitors, in patients with ACS after complete revasculariazation, in patients implanted with CIED
cardiovascular death
时间窗: 10 years
death due to cardiovascular etiology during long term follow-up
Time to revascularization
时间窗: 10 years
Time to revascularization during acute coronary syndrome
Bleeding complications
时间窗: 10 years
Bleeding complications during long-term follow-up in patients prescribed with oral anticoagulation and/or antithrombotic therapy
次要结局
未报告次要终点
研究者
Ivan Zeljkovic
M.D., Ph.D., Associate Professor
University Hospital Dubrava
